HIF-Dependent Antitumorigenic Effect of Antioxidants In Vivo

Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Cancer Cell (Impact Factor: 23.52). 10/2007; 12(3):230-8. DOI: 10.1016/j.ccr.2007.08.004
Source: PubMed


The antitumorigenic activity of antioxidants has been presumed to arise from their ability to squelch DNA damage and genomic instability mediated by reactive oxygen species (ROS). Here, we report that antioxidants inhibited three tumorigenic models in vivo. Inhibition of a MYC-dependent human B lymphoma model was unassociated with genomic instability but was linked to diminished hypoxia-inducible factor (HIF)-1 levels in a prolyl hydroxylase 2 and von Hippel-Lindau protein-dependent manner. Ectopic expression of an oxygen-independent, stabilized HIF-1 mutant rescued lymphoma xenografts from inhibition by two antioxidants: N-acetylcysteine and vitamin C. These findings challenge the paradigm that antioxidants diminish tumorigenesis primarily through decreasing DNA damage and mutations and provide significant support for a key antitumorigenic effect of diminishing HIF levels.

Download full-text


Available from: Dean Felsher,
  • Source
    • "Many anticancer therapies rely on ROS-induced apoptosis. Although generic antioxidant effects on tumor growth are still debated (Gao et al., 2007; Sayin et al., 2014), mitoTEMPO compared to less selective antioxidants preserves physiological ROS signaling (as shown in nonmalignant fibroblasts; Nazarewicz et al., 2013a) and could therefore selectively target tumor cells with abnormal mitochondrial activities. Although we did not find significant primary tumor growth inhibition using mitoTEMPO at 0.7 mg/kg/day (Figure S5E), others (Nazarewicz et al., 2013a) have shown that the therapeutic effects of this drug at higher dose may retard primary tumor growth. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Metastatic progression of cancer is associated with poor outcome, and here we examine metabolic changes underlying this process. Although aerobic glycolysis is known to promote metastasis, we have now identified a different switch primarily affecting mitochondria. The switch involves overload of the electron transport chain (ETC) with preserved mitochondrial functions but increased mitochondrial superoxide production. It provides a metastatic advantage phenocopied by partial ETC inhibition, another situation associated with enhanced superoxide production. Both cases involved protein tyrosine kinases Src and Pyk2 as downstream effectors. Thus, two different events, ETC overload and partial ETC inhibition, promote superoxide-dependent tumor cell migration, invasion, clonogenicity, and metastasis. Consequently, specific scavenging of mitochondrial superoxide with mitoTEMPO blocked tumor cell migration and prevented spontaneous tumor metastasis in murine and human tumor models.
    Cancer Research 07/2014; 74(19 Supplement). DOI:10.1016/j.celrep.2014.06.043 · 9.33 Impact Factor
  • Source
    • "Anticarcinogenic capacity of curcumin is shown in our study by down regulation of expression of HIF-1α and cMyc towards normal level. Antitumorigenic effect of antioxidants is reported to be dependent on HIF-1α in vivo [46]. Our result of decreased expression and activity of LDH-A, by curcumin treatment suggests inhibition of cellular transformation and in vivo tumorigenesis as reported earlier [47]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Oxidative stress, an important factor in modulation of glycolytic pathway and induction of stress activated genes, is further augmented due to reduced antioxidant defense system, which promotes cancer progression via inducing angiogenesis. Curcumin, a naturally occurring chemopreventive phytochemical, is reported to inhibit carcinogenesis in various experimental animal models. However, the underlying mechanism involved in anticarcinogenic action of curcumin due to its long term effect is still to be reported because of its rapid metabolism, although metabolites are accumulated in tissues and remain for a longer time. Therefore, the long term effect of curcumin needs thorough investigation. The present study aimed to analyze the anticarcinogenic action of curcumin in liver, even after withdrawal of treatment in Dalton's lymphoma bearing mice. Oxidative stress observed during lymphoma progression reduced antioxidant enzyme activities, and induced angiogenesis as well as activation of early stress activated genes and glycolytic pathway. Curcumin treatment resulted in activation of antioxidant enzyme super oxide dismutase and down regulation of ROS level as well as activity of ROS producing enzyme NADPH:oxidase, expression of stress activated genes HIF-1α, cMyc and LDH activity towards normal level. Further, it lead to significant inhibition of angiogenesis, observed via MMPs activity, PKCα and VEGF level, as well as by matrigel plug assay. Thus findings of this study conclude that the long term effect of curcumin shows anticarcinogenic potential via induction of antioxidant defense system and inhibition of angiogenesis via down regulation of stress activated genes and glycolytic pathway in liver of lymphoma bearing mice.
    PLoS ONE 06/2014; 9(6):e99583. DOI:10.1371/journal.pone.0099583 · 3.23 Impact Factor
  • Source
    • "The ability of reactive oxygen species (ROS) to promote HIF-1α stabilization suggests that the use of antioxidants can suppress tumorigenesis through modulation of HIF-1α 18. In a similar fashion, REDD1 can regulate production of ROS in mitochondria of embryonic fibroblast cells 12. Thus, as HIF-1α and REDD1 are redox-responsive proteins, changes in the intracellular redox environment with exogenous antioxidants would be expected to enhance their impact on apoptosis and growth inhibition. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Methylseleninic acid (MSeA) is a monomethylated selenium metabolite theoretically derived from subsequent β-lyase or transamination reactions of dietary Se-methylselenocysteine that has potent antitumor activity by inhibiting cell proliferation of several cancers. Our previous studies showed that MSeA promotes apoptosis in invasive prostate cancer cells in part by downregulating hypoxia-inducible factor HIF-1α. We have now extended these studies to evaluate the impact of MSeA on REDD1 (an mTOR inhibitor) in inducing cell death of invasive prostate cancer cells in hypoxia. In both PTEN+ and PTEN− prostate cancer cells we show that MSeA elevates REDD1 and phosphorylation of AKT along with p70S6K in hypoxia. Furthermore, REDD1 induction by MSeA is independent of AKT and the mTOR inhibition in prostate cancer cells causes partial resistance to MSeA-induced growth reduction in hypoxia. Our data suggest that MSeA induces REDD1 and inhibits prostate cancer cell growth in hypoxia despite activation of AKT and dysregulation of mTOR. MSeA elevates REDD1 and AKT to promote cell death in invasive prostate cancer cells in hypoxia.
    Cancer Medicine 04/2014; 3(2). DOI:10.1002/cam4.198 · 2.50 Impact Factor
Show more